Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals.

Rizza, Stacey A

Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals. [electronic resource] - AIDS (London, England) Nov 2010 - 2639-44 p. digital

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

1473-5571

10.1097/QAD.0b013e32833eacfd doi


Adult
Antiviral Agents--administration & dosage
Canada
Drug Therapy, Combination
Female
HIV Infections--complications
Hepatitis C, Chronic--complications
Humans
Interferon alpha-2
Interferon-alpha--administration & dosage
Liver Diseases--drug therapy
Male
Middle Aged
Polymorphism, Genetic
RNA, Viral
Receptors, Tumor Necrosis Factor, Member 25--genetics
Recombinant Proteins
Ribavirin--administration & dosage